Recursion Pharmaceuticals, Inc. (RXRX)

3.65 +0.09 (+2.53%) USD  |  NASDAQ  |  Apr 22, 13:53
More

Recursion Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Geron Corp. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade